CoChat

Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease

Open access
Finkelman, Malcolm A. · 2020 · Journal of Fungi

The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.

Abstract

(1→3)-β-glucan (BDG) testing as an adjunct in the diagnosis of invasive fungal disease (IFD) has been in use for nearly three decades. While BDG has a very high negative predictive value in this setting, diagnostic false positives may occur, limiting specificity and positive predictive value. Although results may be diagnostically false positive, they are analytically correct, due to the presence of BDG in the circulation. This review surveys the non-IFD causes of elevated circulating BDG. These are in the main, iatrogenic patient contamination through the use of BDG-containing medical devices and parenterally-delivered materials as well as translocation of intestinal luminal BDG due to mucosal barrier injury. Additionally, infection with Nocardia sp. may also contribute to elevated circulating BDG. Knowledge of the factors which may contribute to such non-IFD-related test results can improve the planning and interpretation of BDG assays and permit investigational strategies, such as serial sampling and BDG clearance evaluation, to assess the likelihood of contamination and improve patient care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jof7010014

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Limulus amebocyte lysate cascade.
Figure 1 Limulus amebocyte lysate cascade.CC BY · PubMed Central
Figure 2 Kinetic analysis of BDG activation of LAL cascade [Unpublished data, Associates of Cape Cod, Inc.]. BDG: (1→3)-β-glucan; LAL: Limulus amebocyte lysate.
Figure 2 Kinetic analysis of BDG activation of LAL cascade [Unpublished data, Associates of Cape Cod, Inc.]. BDG: (1→3)-β-glucan; LAL: Limulus amebocyte lysate.CC BY · PubMed Central
Figure 3 Fungal BDG: (1→3)-β-glucan backbone with (1→6)-β-linked glucose.
Figure 3 Fungal BDG: (1→3)-β-glucan backbone with (1→6)-β-linked glucose.CC BY · PubMed Central
Figure 4 Pre-and post IVg infusion effect upon serum BDG titer [Unpublished data, Associates of Cape Cod, Inc.].
Figure 4 Pre-and post IVg infusion effect upon serum BDG titer [Unpublished data, Associates of Cape Cod, Inc.].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Menon, A., Ruhe, J., Finkelman, M.A., Bariola, R., and Woods, G. (2007, January 4–7). (1→3)-β-d-Glucan (BG) Assay for Diagnosis of Invasive Fungal Infections (IFI). Proceedings of the IDSA Annual Meeting, San Diego, CA, USA.

Cited by

See all 78

Metadata

Authors
Finkelman, M. A.
Affiliations
Associates of Cape Cod, Inc., 124 Bernard E. St. Jean Drive, East Falmouth, MA 02536, USA
Corresponding author
Finkelman, Malcolm A.
Venue
Journal of Fungi
Publisher
MDPI AG
Published
2020-12-29
Volume
7
Issue
1
Pages
14
ISSN
2309-608X (ISSN-L)
OpenAlex
W3116706280
Cited by
76
References
128
Citations by year
2026: 8 · 2025: 15 · 2024: 15 · 2023: 15 · 2022: 8 · 2021: 15
FWCI
0.45
Type
journal article
Language
en
Open access
Locations
  • Journal of Fungi (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
β-1,3-glucan, invasive fungal infections, diagnostic specificity, false positives, medical device contamination, intestinal translocation, mucosal barrier injury, Nocardia, serial sampling, diagnostic test interpretation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.